Benign prostatic hypertrophy: update on drug therapy
Can Fam Physician. 2006 Sep;52(9):1075-6, 1077-8.
[Article in
English,
French]
No abstract available
MeSH terms
-
Aged
-
Androgen Antagonists / adverse effects
-
Androgen Antagonists / therapeutic use*
-
Azasteroids / adverse effects
-
Azasteroids / therapeutic use
-
Canada
-
Dose-Response Relationship, Drug
-
Dutasteride
-
Enzyme Inhibitors / adverse effects
-
Enzyme Inhibitors / therapeutic use
-
Finasteride / adverse effects
-
Finasteride / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Prognosis
-
Prostatic Hyperplasia / diagnosis
-
Prostatic Hyperplasia / drug therapy*
-
Randomized Controlled Trials as Topic
-
Severity of Illness Index
-
Treatment Outcome
Substances
-
Androgen Antagonists
-
Azasteroids
-
Enzyme Inhibitors
-
Finasteride
-
Dutasteride